Valion Bio Inc (VBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,470 | -4,178 | -2,747 | -1,481 | -8,244 |
| Depreciation Amortization | 352 | 79 | 78 | 46 | 182 |
| Accounts receivable | N/A | 160 | 153 | 100 | -67 |
| Accounts payable and accrued liabilities | -588 | -380 | -267 | -166 | -610 |
| Other Working Capital | -1,193 | -448 | -396 | -281 | -752 |
| Other Operating Activity | 174 | 407 | 226 | 116 | 980 |
| Operating Cash Flow | $-5,725 | $-4,360 | $-2,953 | $-1,666 | $-8,511 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -118 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-118 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,381 | 3,266 | 3,251 | N/A | 8,507 |
| Other Financing Activity | -49 | -112 | 0 | -61 | 0 |
| Financing Cash Flow | $4,332 | $3,154 | $3,251 | $-61 | $8,507 |
| Beginning Cash Position | 3,395 | 3,395 | 3,395 | 3,395 | 3,517 |
| End Cash Position | 2,002 | 2,189 | 3,693 | 1,668 | 3,395 |
| Net Cash Flow | $-1,393 | $-1,206 | $298 | $-1,727 | $-122 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,725 | -4,360 | -2,953 | -1,666 | -8,511 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -118 |
| Free Cash Flow | -5,725 | -4,360 | -2,953 | -1,666 | -8,629 |